The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.3M Compounds and 9.4K Targets. Of those, 1,412K data for 665K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.EBI
R. C. Patel Institute of Pharmaceutical Education and Research
Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.EBI
University of Ljubljana
Biological activities of novel gyrase inhibitors of the aminocoumarin class.EBI
UniversitäT TüBingen
Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry.EBI
Purdue University
Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria.EBI
Experimental Therapeutics Centre
Synthesis and antimycobacterial activity of 1-(?-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.EBI
University of Delhi
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.EBI
University of Ljubljana
Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.EBI
University of Ljubljana
Bacterial topoisomerase I inhibitors with antibacterial activityBDB
The Florida International University Board of Trustees